iSpecimen Inc. (ISPC) stock
ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3028% below fair value
$0.71−0.03 (-3.81%)
Close on Nov 11, 2026Market cap $1.79MP/E –Yield –
iSpecimen enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
iSpecimen's enterprise value was -$3.33M on Nov 11, 2026, against $1.32M a year earlier. Over the last 5 years it ranged from -$9.58M to $44.61M, with a median of -$241.31K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.33M | – |
| 2025 | Dec 31, 2025 | -$241.31K | -153.5% |
| 2024 | Dec 31, 2024 | $451.37K | – |
| 2023 | Dec 29, 2023 | -$1.12M | – |
| 2022 | Dec 30, 2022 | -$8.44M | -118.9% |
| 2021 | Dec 31, 2021 | $44.61M | – |
See a number that looks wrong?